The ParaNano team is headed to HLTH 2023 in Las Vegas this morning!
Special thanks to #BLUEKNIGHT and JLABS for the opportunity to be part of their Innovation Pavilion.
Looking forward to networking and sharing the ParaNano Wound Care, LLC vision at booth 4546 - Kiosk #7.
Come by and see us!
https://blubrry.com/1473485/118082128/color-coding-wound-infection-with-chelsea-luxen-of-paranano-wound-care/
https://www.linkedin.com/posts/chelsea-luxen-mba-249234b4_medtechimpactpodcast-impact-medtech-activity-7107031946156769280-oE5j?utm_source=share&utm_medium=member_desktop
We can't wait to welcome over 1,300 AMR and infectious disease stakeholders to the World AMR Congress!
Join like-minded individuals in the fight against this pressing global issue in Philadelphia this September 7-8 and catch can't-miss sessions from industry leaders, including:
"The Potential of Public-Private Partnerships to Accelerate Early-Stage Innovation"
Blue Knight hosted their annual symposium in conjunction with the Biotechnology Innovation Organization Conference in Boston, MA. ParaNano had the pleasure of presenting a poster and attending the conference representing Oklahoma & Blue Knight.
ParaNano becomes part of the prestigious and exclusive global Blue Knight portfolio.
“This joint initiative was created between Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services. Blue Knight is a collaboration dedicated to anticipating potential health security threats, activating the global innovation community, and amplifying scientific and technological advancements with the aim to prepare for and respond to our rapidly evolving global health environment.”
https://jnjinnovation.com/jlabs/blue-knight
https://jnjinnovation.com/JLABSNavigator/company/ParaNano_Wound_Care,_LLC
https://youtu.be/0VPThtTTCPc?si=7TLISWyrpZyt-U-Y
Thrilled to announce that Chelsea Luxen & ParaNano won two awards at the UMass M2D2 Impact Accelerator Pitch Off event sponsored by Johnson & Johnson Innovation. ParaNano was awarded “Most Innovative” and Chelsea secured “Best Pitch-Off Presentation.”
“Just Keep Going...” Chelsea Larsen, CEO, and Co-Founder of ParaNano Wound Care (ParaNano) shared words of encouragement to hopeful entrepreneurs about the journey from technology ideation to commercialization in an interview with OK Catalyst. True to Oklahoma and its entrepreneurial spirit, perseverance is at the heart of startup success. Over the next few months, we'll be sharing an unfiltered look at how tech startups across Oklahoma are forging ahead despite adversity. If we know one thing is true, we all have a thing or two to learn from those who came before us.
Great news! We’ve been selected to participate in the @UMassM2D2 IMPACT Accelerator Cycle 4 Cohort, sponsored by @Johnson & Johnson Innovation. On November 30th , we’ll pitch our #MedicalDevice #Innovation at the IMPACT Accelerator Pitch-off.
We’re thrilled about this opportunity to work closely with M2D2 and present our idea to major investors in the #LifeSciences ecosystem. We hope you’ll attend to show your support.
https://www.linkedin.com/posts/chelsea-luxen-mba-249234b4_medicaldevice-lifesciences-startups-activity-7003032602567725056-hdfi?utm_source=share&utm_medium=member_desktop
#M2D2IMPACT
Check out pages 12 & 13 for a Q&A featuring yours truly regarding nanofibers & wound care!
I am honored to be featured in the premier issue of MD Next.